Insightec, a Haifa, Israel- and Miami, FL-based healthcare company dedicated to using focused ultrasound to improve patient care, raised $150M in equity funding.
The round was led by Fidelity Management & Research Company and co-led by Nexus Neurotech Ventures and Ally Bridge Group. Other investors included Baillie Gifford, Catalio Capital Management, Fayez Sarofim & Co., Gilmartin Capital, York Global Finance / Community Fund and Perceptive Advisors.
The company intends to use the funds to expand operations and its development efforts.
Led by CEO Maurice R Ferré, Insightec is a global healthcare company providing the Exablate Prime platform which provides tremor treatment to patients with medication-refractory essential tremor and Parkinson’s disease. With over 160 systems installed worldwide, Insightec’s proprietary technology has been used in nearly 20,000 commercial applications and is currently FDA approved as an incisionless, immediate treatment for patients suffering from essential tremor and Parkinson’s disease.
The company has offices in Dallas, Shanghai, and Tokyo.
FinSMEs
19/06/2024